MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 233 filers reported holding MYRIAD GENETICS INC in Q4 2015. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $85,000 | -94.2% | 2,713 | -94.3% | 0.00% | -100.0% |
Q1 2021 | $1,456,000 | -75.9% | 47,802 | -84.4% | 0.01% | -73.9% |
Q4 2020 | $6,047,000 | +51.7% | 305,801 | 0.0% | 0.02% | +35.3% |
Q3 2020 | $3,987,000 | -31.6% | 305,801 | -40.5% | 0.02% | -32.0% |
Q2 2020 | $5,831,000 | -29.8% | 514,094 | -11.5% | 0.02% | -47.9% |
Q1 2020 | $8,312,000 | -61.5% | 580,879 | -26.8% | 0.05% | -51.0% |
Q4 2019 | $21,597,000 | -8.5% | 793,173 | -3.8% | 0.10% | -3.0% |
Q3 2019 | $23,609,000 | -34.6% | 824,618 | -36.5% | 0.10% | -41.6% |
Q2 2019 | $36,096,000 | -27.8% | 1,299,374 | -13.8% | 0.17% | -19.5% |
Q1 2019 | $50,020,000 | -7.6% | 1,506,584 | -19.1% | 0.22% | -19.8% |
Q4 2018 | $54,138,000 | -50.7% | 1,862,279 | -22.0% | 0.27% | -41.0% |
Q3 2018 | $109,812,000 | +26.2% | 2,387,166 | +2.6% | 0.45% | +20.7% |
Q2 2018 | $86,988,000 | +23.6% | 2,327,720 | -2.2% | 0.38% | +23.7% |
Q1 2018 | $70,351,000 | -7.1% | 2,380,782 | +8.0% | 0.30% | -7.3% |
Q4 2017 | $75,743,000 | +12.4% | 2,205,297 | +18.4% | 0.33% | +10.1% |
Q3 2017 | $67,373,000 | +71.1% | 1,862,101 | +22.2% | 0.30% | +67.4% |
Q2 2017 | $39,387,000 | +15.0% | 1,524,266 | -14.5% | 0.18% | +13.4% |
Q1 2017 | $34,246,000 | +6.4% | 1,783,748 | -7.6% | 0.16% | +0.6% |
Q4 2016 | $32,190,000 | -43.7% | 1,930,989 | -30.5% | 0.16% | -44.9% |
Q3 2016 | $57,152,000 | +323.0% | 2,777,044 | +528.9% | 0.28% | +310.1% |
Q2 2016 | $13,510,000 | +115.5% | 441,552 | +163.6% | 0.07% | +115.6% |
Q1 2016 | $6,270,000 | -9.6% | 167,524 | +4.3% | 0.03% | -11.1% |
Q4 2015 | $6,935,000 | +43243.8% | 160,682 | +37442.5% | 0.04% | – |
Q3 2015 | $16,000 | -15.8% | 428 | -26.0% | 0.00% | – |
Q2 2015 | $19,000 | +58.3% | 578 | +80.6% | 0.00% | – |
Q1 2015 | $12,000 | +9.1% | 320 | 0.0% | 0.00% | – |
Q4 2014 | $11,000 | -99.9% | 320 | -99.8% | 0.00% | -100.0% |
Q3 2014 | $7,852,000 | -68.6% | 203,554 | -68.3% | 0.04% | -68.6% |
Q2 2014 | $24,967,000 | +30723.5% | 641,524 | +27014.3% | 0.12% | – |
Q1 2014 | $81,000 | -98.5% | 2,366 | -99.1% | 0.00% | -100.0% |
Q4 2013 | $5,249,000 | -59.7% | 250,207 | -54.8% | 0.03% | -65.5% |
Q3 2013 | $13,014,000 | – | 553,752 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |